Innovation in Disease Prevention
A Fortune 100 biopharmaceutical company pursued an initiative focused on identifying and developing product concepts for disease prevention.
World’s Largest CRO Leverages Partnership With Integrated Central IBC to Initiate Sites in COVID-19 Vaccine Research at Warp Speed
Advarra’s IRB and IBC reviews and Gene Therapy Ready site network helped reduce study startup timelines and delivered trial results to the sponsor quicker than expected.
Meridian Builds Robust Gene Therapy Research Program
Partnering with Advarra’s Institutional Biosafety Committee, Meridian Clinical Research established a program for conducting clinical trials with cutting edge, genetically engineered vaccines.
Leveraging a Central IRB Office to Improve Turnaround Times and Consistency
Research Site Dramatically Increases Funding through Advarra’s Budget Negotiation Service
Utilizing Advarra’s Budget Negotiation Service enabled a research site to accelerate their timeline, alleviate budget negotiation burdens, and ensure their funding goals.